nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticlopidine—CYP2E1—Fingolimod—multiple sclerosis	0.148	0.208	CbGbCtD
Ticlopidine—CYP2D6—Fingolimod—multiple sclerosis	0.0703	0.0992	CbGbCtD
Ticlopidine—CYP2E1—Mitoxantrone—multiple sclerosis	0.0694	0.0979	CbGbCtD
Ticlopidine—CYP1A1—Dexamethasone—multiple sclerosis	0.0466	0.0657	CbGbCtD
Ticlopidine—CYP3A4—Fingolimod—multiple sclerosis	0.0447	0.0631	CbGbCtD
Ticlopidine—CYP2C19—Prednisone—multiple sclerosis	0.0361	0.051	CbGbCtD
Ticlopidine—CYP2E1—Dexamethasone—multiple sclerosis	0.036	0.0508	CbGbCtD
Ticlopidine—CYP2B6—Dexamethasone—multiple sclerosis	0.0355	0.0501	CbGbCtD
Ticlopidine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0288	0.0407	CbGbCtD
Ticlopidine—CYP2C8—Dexamethasone—multiple sclerosis	0.0269	0.0379	CbGbCtD
Ticlopidine—CYP2C19—Dexamethasone—multiple sclerosis	0.0225	0.0318	CbGbCtD
Ticlopidine—CYP3A4—Triamcinolone—multiple sclerosis	0.0218	0.0308	CbGbCtD
Ticlopidine—CYP3A4—Mitoxantrone—multiple sclerosis	0.021	0.0297	CbGbCtD
Ticlopidine—CYP2C9—Dexamethasone—multiple sclerosis	0.0187	0.0265	CbGbCtD
Ticlopidine—CYP3A4—Betamethasone—multiple sclerosis	0.0187	0.0264	CbGbCtD
Ticlopidine—CYP3A4—Prednisolone—multiple sclerosis	0.0185	0.0261	CbGbCtD
Ticlopidine—CYP3A4—Prednisone—multiple sclerosis	0.0175	0.0246	CbGbCtD
Ticlopidine—CYP2D6—Dexamethasone—multiple sclerosis	0.0171	0.0242	CbGbCtD
Ticlopidine—CYP3A4—Dexamethasone—multiple sclerosis	0.0109	0.0154	CbGbCtD
Ticlopidine—Vasculitis—Prednisone—multiple sclerosis	0.000778	0.00422	CcSEcCtD
Ticlopidine—Headache—Fingolimod—multiple sclerosis	0.000764	0.00415	CcSEcCtD
Ticlopidine—Pancytopenia—Mitoxantrone—multiple sclerosis	0.000759	0.00412	CcSEcCtD
Ticlopidine—Osteoarthritis—Prednisolone—multiple sclerosis	0.000759	0.00412	CcSEcCtD
Ticlopidine—Erythema multiforme—Azathioprine—multiple sclerosis	0.000748	0.00406	CcSEcCtD
Ticlopidine—Diabetes mellitus—Betamethasone—multiple sclerosis	0.000728	0.00395	CcSEcCtD
Ticlopidine—Diabetes mellitus—Dexamethasone—multiple sclerosis	0.000728	0.00395	CcSEcCtD
Ticlopidine—Purpura—Triamcinolone—multiple sclerosis	0.000724	0.00393	CcSEcCtD
Ticlopidine—Myalgia—Cladribine—multiple sclerosis	0.000721	0.00391	CcSEcCtD
Ticlopidine—Arthralgia—Cladribine—multiple sclerosis	0.000721	0.00391	CcSEcCtD
Ticlopidine—Renal failure—Mitoxantrone—multiple sclerosis	0.000701	0.0038	CcSEcCtD
Ticlopidine—Osteoarthritis—Triamcinolone—multiple sclerosis	0.000698	0.00379	CcSEcCtD
Ticlopidine—Osteoarthritis—Methylprednisolone—multiple sclerosis	0.000696	0.00378	CcSEcCtD
Ticlopidine—Ecchymosis—Prednisone—multiple sclerosis	0.000687	0.00373	CcSEcCtD
Ticlopidine—Haematuria—Mitoxantrone—multiple sclerosis	0.00068	0.00369	CcSEcCtD
Ticlopidine—Thrombocytopenia—Cladribine—multiple sclerosis	0.000677	0.00367	CcSEcCtD
Ticlopidine—Abdominal distension—Prednisolone—multiple sclerosis	0.00066	0.00358	CcSEcCtD
Ticlopidine—Anorexia—Cladribine—multiple sclerosis	0.000659	0.00358	CcSEcCtD
Ticlopidine—Sepsis—Prednisone—multiple sclerosis	0.000659	0.00358	CcSEcCtD
Ticlopidine—Vasculitis—Methotrexate—multiple sclerosis	0.00065	0.00353	CcSEcCtD
Ticlopidine—Haemoglobin—Mitoxantrone—multiple sclerosis	0.000643	0.00349	CcSEcCtD
Ticlopidine—Haemorrhage—Mitoxantrone—multiple sclerosis	0.00064	0.00347	CcSEcCtD
Ticlopidine—Hepatitis—Mitoxantrone—multiple sclerosis	0.00064	0.00347	CcSEcCtD
Ticlopidine—Diabetes mellitus—Prednisone—multiple sclerosis	0.000634	0.00344	CcSEcCtD
Ticlopidine—Osteoarthritis—Dexamethasone—multiple sclerosis	0.000633	0.00344	CcSEcCtD
Ticlopidine—Osteoarthritis—Betamethasone—multiple sclerosis	0.000633	0.00344	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Cladribine—multiple sclerosis	0.00063	0.00342	CcSEcCtD
Ticlopidine—Vascular purpura—Prednisone—multiple sclerosis	0.000616	0.00334	CcSEcCtD
Ticlopidine—Abdominal distension—Triamcinolone—multiple sclerosis	0.000607	0.00329	CcSEcCtD
Ticlopidine—Abdominal distension—Methylprednisolone—multiple sclerosis	0.000606	0.00329	CcSEcCtD
Ticlopidine—Decreased appetite—Cladribine—multiple sclerosis	0.000601	0.00326	CcSEcCtD
Ticlopidine—Pain—Cladribine—multiple sclerosis	0.000591	0.00321	CcSEcCtD
Ticlopidine—Myalgia—Azathioprine—multiple sclerosis	0.000587	0.00318	CcSEcCtD
Ticlopidine—Arthralgia—Azathioprine—multiple sclerosis	0.000587	0.00318	CcSEcCtD
Ticlopidine—Ecchymosis—Methotrexate—multiple sclerosis	0.000574	0.00311	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Prednisolone—multiple sclerosis	0.000573	0.00311	CcSEcCtD
Ticlopidine—Purpura—Prednisone—multiple sclerosis	0.000572	0.0031	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Cladribine—multiple sclerosis	0.000566	0.00307	CcSEcCtD
Ticlopidine—Osteoarthritis—Prednisone—multiple sclerosis	0.000551	0.00299	CcSEcCtD
Ticlopidine—Gastrointestinal haemorrhage—Prednisone—multiple sclerosis	0.000551	0.00299	CcSEcCtD
Ticlopidine—Sepsis—Methotrexate—multiple sclerosis	0.000551	0.00299	CcSEcCtD
Ticlopidine—Thrombocytopenia—Azathioprine—multiple sclerosis	0.000551	0.00299	CcSEcCtD
Ticlopidine—Urticaria—Cladribine—multiple sclerosis	0.000549	0.00298	CcSEcCtD
Ticlopidine—Body temperature increased—Cladribine—multiple sclerosis	0.000547	0.00297	CcSEcCtD
Ticlopidine—Diabetes mellitus—Methotrexate—multiple sclerosis	0.00053	0.00287	CcSEcCtD
Ticlopidine—Haemoglobin—Prednisolone—multiple sclerosis	0.000528	0.00286	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Triamcinolone—multiple sclerosis	0.000527	0.00286	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Methylprednisolone—multiple sclerosis	0.000526	0.00285	CcSEcCtD
Ticlopidine—Haemorrhage—Prednisolone—multiple sclerosis	0.000525	0.00285	CcSEcCtD
Ticlopidine—Hepatic failure—Methotrexate—multiple sclerosis	0.000513	0.00278	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.000512	0.00278	CcSEcCtD
Ticlopidine—Hypersensitivity—Cladribine—multiple sclerosis	0.00051	0.00277	CcSEcCtD
Ticlopidine—Epistaxis—Triamcinolone—multiple sclerosis	0.000507	0.00275	CcSEcCtD
Ticlopidine—Asthenia—Cladribine—multiple sclerosis	0.000496	0.00269	CcSEcCtD
Ticlopidine—Pruritus—Cladribine—multiple sclerosis	0.000489	0.00266	CcSEcCtD
Ticlopidine—Dermatitis exfoliative—Methotrexate—multiple sclerosis	0.000488	0.00265	CcSEcCtD
Ticlopidine—Haemoglobin—Triamcinolone—multiple sclerosis	0.000485	0.00263	CcSEcCtD
Ticlopidine—Haemoglobin—Methylprednisolone—multiple sclerosis	0.000484	0.00263	CcSEcCtD
Ticlopidine—Haemorrhage—Triamcinolone—multiple sclerosis	0.000483	0.00262	CcSEcCtD
Ticlopidine—Haemorrhage—Methylprednisolone—multiple sclerosis	0.000482	0.00261	CcSEcCtD
Ticlopidine—Abdominal distension—Prednisone—multiple sclerosis	0.00048	0.0026	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Dexamethasone—multiple sclerosis	0.000478	0.0026	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Betamethasone—multiple sclerosis	0.000478	0.0026	CcSEcCtD
Ticlopidine—Myalgia—Mitoxantrone—multiple sclerosis	0.000474	0.00257	CcSEcCtD
Ticlopidine—Arthralgia—Mitoxantrone—multiple sclerosis	0.000474	0.00257	CcSEcCtD
Ticlopidine—Diarrhoea—Cladribine—multiple sclerosis	0.000473	0.00257	CcSEcCtD
Ticlopidine—Osteoarthritis—Methotrexate—multiple sclerosis	0.000461	0.0025	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.00046	0.0025	CcSEcCtD
Ticlopidine—Dizziness—Cladribine—multiple sclerosis	0.000457	0.00248	CcSEcCtD
Ticlopidine—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000455	0.00247	CcSEcCtD
Ticlopidine—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000445	0.00242	CcSEcCtD
Ticlopidine—Body temperature increased—Azathioprine—multiple sclerosis	0.000445	0.00241	CcSEcCtD
Ticlopidine—Haemoglobin—Dexamethasone—multiple sclerosis	0.00044	0.00239	CcSEcCtD
Ticlopidine—Haemoglobin—Betamethasone—multiple sclerosis	0.00044	0.00239	CcSEcCtD
Ticlopidine—Vomiting—Cladribine—multiple sclerosis	0.00044	0.00239	CcSEcCtD
Ticlopidine—Haemorrhage—Betamethasone—multiple sclerosis	0.000438	0.00238	CcSEcCtD
Ticlopidine—Haemorrhage—Dexamethasone—multiple sclerosis	0.000438	0.00238	CcSEcCtD
Ticlopidine—Rash—Cladribine—multiple sclerosis	0.000436	0.00237	CcSEcCtD
Ticlopidine—Dermatitis—Cladribine—multiple sclerosis	0.000436	0.00236	CcSEcCtD
Ticlopidine—Anorexia—Mitoxantrone—multiple sclerosis	0.000433	0.00235	CcSEcCtD
Ticlopidine—Headache—Cladribine—multiple sclerosis	0.000433	0.00235	CcSEcCtD
Ticlopidine—Liver function test abnormal—Methotrexate—multiple sclerosis	0.000425	0.00231	CcSEcCtD
Ticlopidine—Angioedema—Prednisolone—multiple sclerosis	0.000418	0.00227	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Prednisone—multiple sclerosis	0.000417	0.00226	CcSEcCtD
Ticlopidine—Hypersensitivity—Azathioprine—multiple sclerosis	0.000414	0.00225	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000414	0.00225	CcSEcCtD
Ticlopidine—Nausea—Cladribine—multiple sclerosis	0.000411	0.00223	CcSEcCtD
Ticlopidine—Dyspepsia—Mitoxantrone—multiple sclerosis	0.0004	0.00217	CcSEcCtD
Ticlopidine—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000395	0.00214	CcSEcCtD
Ticlopidine—Eosinophilia—Methotrexate—multiple sclerosis	0.000394	0.00214	CcSEcCtD
Ticlopidine—Pain—Mitoxantrone—multiple sclerosis	0.000389	0.00211	CcSEcCtD
Ticlopidine—Diarrhoea—Azathioprine—multiple sclerosis	0.000385	0.00209	CcSEcCtD
Ticlopidine—Angioedema—Triamcinolone—multiple sclerosis	0.000384	0.00208	CcSEcCtD
Ticlopidine—Haemoglobin—Prednisone—multiple sclerosis	0.000383	0.00208	CcSEcCtD
Ticlopidine—Angioedema—Methylprednisolone—multiple sclerosis	0.000383	0.00208	CcSEcCtD
Ticlopidine—Haemorrhage—Prednisone—multiple sclerosis	0.000381	0.00207	CcSEcCtD
Ticlopidine—Pancytopenia—Methotrexate—multiple sclerosis	0.000378	0.00205	CcSEcCtD
Ticlopidine—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000373	0.00202	CcSEcCtD
Ticlopidine—Dizziness—Azathioprine—multiple sclerosis	0.000372	0.00202	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000372	0.00202	CcSEcCtD
Ticlopidine—Urticaria—Mitoxantrone—multiple sclerosis	0.000361	0.00196	CcSEcCtD
Ticlopidine—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000359	0.00195	CcSEcCtD
Ticlopidine—Myalgia—Triamcinolone—multiple sclerosis	0.000358	0.00194	CcSEcCtD
Ticlopidine—Vomiting—Azathioprine—multiple sclerosis	0.000358	0.00194	CcSEcCtD
Ticlopidine—Arthralgia—Methylprednisolone—multiple sclerosis	0.000357	0.00194	CcSEcCtD
Ticlopidine—Myalgia—Methylprednisolone—multiple sclerosis	0.000357	0.00194	CcSEcCtD
Ticlopidine—Rash—Azathioprine—multiple sclerosis	0.000355	0.00192	CcSEcCtD
Ticlopidine—Dermatitis—Azathioprine—multiple sclerosis	0.000354	0.00192	CcSEcCtD
Ticlopidine—Headache—Azathioprine—multiple sclerosis	0.000352	0.00191	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000352	0.00191	CcSEcCtD
Ticlopidine—Renal failure—Methotrexate—multiple sclerosis	0.000349	0.00189	CcSEcCtD
Ticlopidine—Angioedema—Dexamethasone—multiple sclerosis	0.000348	0.00189	CcSEcCtD
Ticlopidine—Angioedema—Betamethasone—multiple sclerosis	0.000348	0.00189	CcSEcCtD
Ticlopidine—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000343	0.00186	CcSEcCtD
Ticlopidine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000342	0.00186	CcSEcCtD
Ticlopidine—Haematuria—Methotrexate—multiple sclerosis	0.000339	0.00184	CcSEcCtD
Ticlopidine—Epistaxis—Methotrexate—multiple sclerosis	0.000335	0.00182	CcSEcCtD
Ticlopidine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000335	0.00182	CcSEcCtD
Ticlopidine—Nausea—Azathioprine—multiple sclerosis	0.000334	0.00181	CcSEcCtD
Ticlopidine—Asthenia—Mitoxantrone—multiple sclerosis	0.000326	0.00177	CcSEcCtD
Ticlopidine—Myalgia—Betamethasone—multiple sclerosis	0.000325	0.00176	CcSEcCtD
Ticlopidine—Myalgia—Dexamethasone—multiple sclerosis	0.000325	0.00176	CcSEcCtD
Ticlopidine—Haemoglobin—Methotrexate—multiple sclerosis	0.00032	0.00174	CcSEcCtD
Ticlopidine—Pain—Prednisolone—multiple sclerosis	0.000319	0.00173	CcSEcCtD
Ticlopidine—Haemorrhage—Methotrexate—multiple sclerosis	0.000319	0.00173	CcSEcCtD
Ticlopidine—Hepatitis—Methotrexate—multiple sclerosis	0.000319	0.00173	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000312	0.0017	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000312	0.00169	CcSEcCtD
Ticlopidine—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000311	0.00169	CcSEcCtD
Ticlopidine—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000311	0.00169	CcSEcCtD
Ticlopidine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000311	0.00169	CcSEcCtD
Ticlopidine—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000305	0.00165	CcSEcCtD
Ticlopidine—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000305	0.00165	CcSEcCtD
Ticlopidine—Angioedema—Prednisone—multiple sclerosis	0.000303	0.00165	CcSEcCtD
Ticlopidine—Dyspepsia—Triamcinolone—multiple sclerosis	0.000302	0.00164	CcSEcCtD
Ticlopidine—Erythema multiforme—Methotrexate—multiple sclerosis	0.000301	0.00164	CcSEcCtD
Ticlopidine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000301	0.00163	CcSEcCtD
Ticlopidine—Tinnitus—Methotrexate—multiple sclerosis	0.000297	0.00161	CcSEcCtD
Ticlopidine—Anorexia—Betamethasone—multiple sclerosis	0.000297	0.00161	CcSEcCtD
Ticlopidine—Anorexia—Dexamethasone—multiple sclerosis	0.000297	0.00161	CcSEcCtD
Ticlopidine—Urticaria—Prednisolone—multiple sclerosis	0.000296	0.00161	CcSEcCtD
Ticlopidine—Pain—Triamcinolone—multiple sclerosis	0.000293	0.00159	CcSEcCtD
Ticlopidine—Vomiting—Mitoxantrone—multiple sclerosis	0.000289	0.00157	CcSEcCtD
Ticlopidine—Rash—Mitoxantrone—multiple sclerosis	0.000287	0.00156	CcSEcCtD
Ticlopidine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000286	0.00155	CcSEcCtD
Ticlopidine—Headache—Mitoxantrone—multiple sclerosis	0.000285	0.00155	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000284	0.00154	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000284	0.00154	CcSEcCtD
Ticlopidine—Myalgia—Prednisone—multiple sclerosis	0.000283	0.00153	CcSEcCtD
Ticlopidine—Arthralgia—Prednisone—multiple sclerosis	0.000283	0.00153	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.00028	0.00152	CcSEcCtD
Ticlopidine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000275	0.00149	CcSEcCtD
Ticlopidine—Dyspepsia—Betamethasone—multiple sclerosis	0.000274	0.00149	CcSEcCtD
Ticlopidine—Dyspepsia—Dexamethasone—multiple sclerosis	0.000274	0.00149	CcSEcCtD
Ticlopidine—Urticaria—Triamcinolone—multiple sclerosis	0.000272	0.00148	CcSEcCtD
Ticlopidine—Urticaria—Methylprednisolone—multiple sclerosis	0.000272	0.00148	CcSEcCtD
Ticlopidine—Body temperature increased—Triamcinolone—multiple sclerosis	0.000271	0.00147	CcSEcCtD
Ticlopidine—Anaphylactic shock—Prednisone—multiple sclerosis	0.000271	0.00147	CcSEcCtD
Ticlopidine—Decreased appetite—Dexamethasone—multiple sclerosis	0.000271	0.00147	CcSEcCtD
Ticlopidine—Decreased appetite—Betamethasone—multiple sclerosis	0.000271	0.00147	CcSEcCtD
Ticlopidine—Nausea—Mitoxantrone—multiple sclerosis	0.00027	0.00147	CcSEcCtD
Ticlopidine—Pain—Betamethasone—multiple sclerosis	0.000266	0.00144	CcSEcCtD
Ticlopidine—Pain—Dexamethasone—multiple sclerosis	0.000266	0.00144	CcSEcCtD
Ticlopidine—Anorexia—Prednisone—multiple sclerosis	0.000258	0.0014	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000254	0.00138	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000254	0.00138	CcSEcCtD
Ticlopidine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000253	0.00137	CcSEcCtD
Ticlopidine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000252	0.00137	CcSEcCtD
Ticlopidine—Urticaria—Betamethasone—multiple sclerosis	0.000247	0.00134	CcSEcCtD
Ticlopidine—Urticaria—Dexamethasone—multiple sclerosis	0.000247	0.00134	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000247	0.00134	CcSEcCtD
Ticlopidine—Dizziness—Prednisolone—multiple sclerosis	0.000247	0.00134	CcSEcCtD
Ticlopidine—Asthenia—Triamcinolone—multiple sclerosis	0.000246	0.00134	CcSEcCtD
Ticlopidine—Body temperature increased—Dexamethasone—multiple sclerosis	0.000246	0.00133	CcSEcCtD
Ticlopidine—Body temperature increased—Betamethasone—multiple sclerosis	0.000246	0.00133	CcSEcCtD
Ticlopidine—Asthenia—Methylprednisolone—multiple sclerosis	0.000246	0.00133	CcSEcCtD
Ticlopidine—Pruritus—Triamcinolone—multiple sclerosis	0.000243	0.00132	CcSEcCtD
Ticlopidine—Pruritus—Methylprednisolone—multiple sclerosis	0.000242	0.00131	CcSEcCtD
Ticlopidine—Dyspepsia—Prednisone—multiple sclerosis	0.000239	0.00129	CcSEcCtD
Ticlopidine—Arthralgia—Methotrexate—multiple sclerosis	0.000236	0.00128	CcSEcCtD
Ticlopidine—Myalgia—Methotrexate—multiple sclerosis	0.000236	0.00128	CcSEcCtD
Ticlopidine—Decreased appetite—Prednisone—multiple sclerosis	0.000236	0.00128	CcSEcCtD
Ticlopidine—Rash—Prednisolone—multiple sclerosis	0.000235	0.00128	CcSEcCtD
Ticlopidine—Dermatitis—Prednisolone—multiple sclerosis	0.000235	0.00127	CcSEcCtD
Ticlopidine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000234	0.00127	CcSEcCtD
Ticlopidine—Headache—Prednisolone—multiple sclerosis	0.000234	0.00127	CcSEcCtD
Ticlopidine—Dizziness—Triamcinolone—multiple sclerosis	0.000227	0.00123	CcSEcCtD
Ticlopidine—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000227	0.00123	CcSEcCtD
Ticlopidine—Dizziness—Methylprednisolone—multiple sclerosis	0.000226	0.00123	CcSEcCtD
Ticlopidine—Asthenia—Dexamethasone—multiple sclerosis	0.000223	0.00121	CcSEcCtD
Ticlopidine—Asthenia—Betamethasone—multiple sclerosis	0.000223	0.00121	CcSEcCtD
Ticlopidine—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000222	0.0012	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000222	0.0012	CcSEcCtD
Ticlopidine—Nausea—Prednisolone—multiple sclerosis	0.000222	0.0012	CcSEcCtD
Ticlopidine—Pruritus—Dexamethasone—multiple sclerosis	0.00022	0.00119	CcSEcCtD
Ticlopidine—Pruritus—Betamethasone—multiple sclerosis	0.00022	0.00119	CcSEcCtD
Ticlopidine—Vomiting—Triamcinolone—multiple sclerosis	0.000218	0.00118	CcSEcCtD
Ticlopidine—Vomiting—Methylprednisolone—multiple sclerosis	0.000218	0.00118	CcSEcCtD
Ticlopidine—Rash—Triamcinolone—multiple sclerosis	0.000216	0.00117	CcSEcCtD
Ticlopidine—Dermatitis—Triamcinolone—multiple sclerosis	0.000216	0.00117	CcSEcCtD
Ticlopidine—Anorexia—Methotrexate—multiple sclerosis	0.000216	0.00117	CcSEcCtD
Ticlopidine—Rash—Methylprednisolone—multiple sclerosis	0.000216	0.00117	CcSEcCtD
Ticlopidine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000216	0.00117	CcSEcCtD
Ticlopidine—Urticaria—Prednisone—multiple sclerosis	0.000215	0.00117	CcSEcCtD
Ticlopidine—Headache—Triamcinolone—multiple sclerosis	0.000215	0.00117	CcSEcCtD
Ticlopidine—Headache—Methylprednisolone—multiple sclerosis	0.000214	0.00116	CcSEcCtD
Ticlopidine—Body temperature increased—Prednisone—multiple sclerosis	0.000214	0.00116	CcSEcCtD
Ticlopidine—Diarrhoea—Betamethasone—multiple sclerosis	0.000213	0.00116	CcSEcCtD
Ticlopidine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000213	0.00116	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000206	0.00112	CcSEcCtD
Ticlopidine—Dizziness—Dexamethasone—multiple sclerosis	0.000206	0.00112	CcSEcCtD
Ticlopidine—Dizziness—Betamethasone—multiple sclerosis	0.000206	0.00112	CcSEcCtD
Ticlopidine—Nausea—Triamcinolone—multiple sclerosis	0.000204	0.00111	CcSEcCtD
Ticlopidine—Nausea—Methylprednisolone—multiple sclerosis	0.000203	0.0011	CcSEcCtD
Ticlopidine—Hypersensitivity—Prednisone—multiple sclerosis	0.0002	0.00108	CcSEcCtD
Ticlopidine—Dyspepsia—Methotrexate—multiple sclerosis	0.000199	0.00108	CcSEcCtD
Ticlopidine—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.000199	0.00186	CbGpPWpGaD
Ticlopidine—Vomiting—Dexamethasone—multiple sclerosis	0.000198	0.00107	CcSEcCtD
Ticlopidine—Vomiting—Betamethasone—multiple sclerosis	0.000198	0.00107	CcSEcCtD
Ticlopidine—Decreased appetite—Methotrexate—multiple sclerosis	0.000197	0.00107	CcSEcCtD
Ticlopidine—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000196	0.00183	CbGpPWpGaD
Ticlopidine—Rash—Betamethasone—multiple sclerosis	0.000196	0.00106	CcSEcCtD
Ticlopidine—Rash—Dexamethasone—multiple sclerosis	0.000196	0.00106	CcSEcCtD
Ticlopidine—Dermatitis—Betamethasone—multiple sclerosis	0.000196	0.00106	CcSEcCtD
Ticlopidine—Dermatitis—Dexamethasone—multiple sclerosis	0.000196	0.00106	CcSEcCtD
Ticlopidine—Headache—Betamethasone—multiple sclerosis	0.000195	0.00106	CcSEcCtD
Ticlopidine—Headache—Dexamethasone—multiple sclerosis	0.000195	0.00106	CcSEcCtD
Ticlopidine—Asthenia—Prednisone—multiple sclerosis	0.000194	0.00106	CcSEcCtD
Ticlopidine—Pain—Methotrexate—multiple sclerosis	0.000194	0.00105	CcSEcCtD
Ticlopidine—P2RY12—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000192	0.00179	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR downstream signaling—CCR1—multiple sclerosis	0.000192	0.00179	CbGpPWpGaD
Ticlopidine—Pruritus—Prednisone—multiple sclerosis	0.000192	0.00104	CcSEcCtD
Ticlopidine—P2RY12—Signaling by GPCR—GPR65—multiple sclerosis	0.000191	0.00178	CbGpPWpGaD
Ticlopidine—Diarrhoea—Prednisone—multiple sclerosis	0.000185	0.00101	CcSEcCtD
Ticlopidine—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000185	0.00173	CbGpPWpGaD
Ticlopidine—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000185	0.00101	CcSEcCtD
Ticlopidine—Nausea—Dexamethasone—multiple sclerosis	0.000185	0.001	CcSEcCtD
Ticlopidine—Nausea—Betamethasone—multiple sclerosis	0.000185	0.001	CcSEcCtD
Ticlopidine—P2RY12—Signaling Pathways—LINGO1—multiple sclerosis	0.000184	0.00172	CbGpPWpGaD
Ticlopidine—P2RY12—G alpha (i) signalling events—POMC—multiple sclerosis	0.000182	0.0017	CbGpPWpGaD
Ticlopidine—P2RY12—Hemostasis—ITGA4—multiple sclerosis	0.000182	0.0017	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR ligand binding—CXCL10—multiple sclerosis	0.000182	0.0017	CbGpPWpGaD
Ticlopidine—P2RY12—Hemostasis—IFNB1—multiple sclerosis	0.000181	0.00169	CbGpPWpGaD
Ticlopidine—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	0.00018	0.00169	CbGpPWpGaD
Ticlopidine—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	0.00018	0.00169	CbGpPWpGaD
Ticlopidine—Urticaria—Methotrexate—multiple sclerosis	0.00018	0.000976	CcSEcCtD
Ticlopidine—Dizziness—Prednisone—multiple sclerosis	0.000179	0.000973	CcSEcCtD
Ticlopidine—Body temperature increased—Methotrexate—multiple sclerosis	0.000179	0.000972	CcSEcCtD
Ticlopidine—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000178	0.00166	CbGpPWpGaD
Ticlopidine—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000178	0.00166	CbGpPWpGaD
Ticlopidine—P2RY12—Platelet activation, signaling and aggregation—ALB—multiple sclerosis	0.000174	0.00163	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—CXCL13—multiple sclerosis	0.000174	0.00163	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—CCR1—multiple sclerosis	0.000174	0.00163	CbGpPWpGaD
Ticlopidine—Vomiting—Prednisone—multiple sclerosis	0.000172	0.000935	CcSEcCtD
Ticlopidine—Rash—Prednisone—multiple sclerosis	0.000171	0.000927	CcSEcCtD
Ticlopidine—Dermatitis—Prednisone—multiple sclerosis	0.000171	0.000926	CcSEcCtD
Ticlopidine—Headache—Prednisone—multiple sclerosis	0.00017	0.000921	CcSEcCtD
Ticlopidine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000167	0.000906	CcSEcCtD
Ticlopidine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000167	0.00156	CbGpPWpGaD
Ticlopidine—MPO—Selenium Micronutrient Network—IL6—multiple sclerosis	0.000164	0.00153	CbGpPWpGaD
Ticlopidine—Asthenia—Methotrexate—multiple sclerosis	0.000163	0.000882	CcSEcCtD
Ticlopidine—Nausea—Prednisone—multiple sclerosis	0.000161	0.000874	CcSEcCtD
Ticlopidine—Pruritus—Methotrexate—multiple sclerosis	0.00016	0.00087	CcSEcCtD
Ticlopidine—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.00016	0.0015	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—TAGAP—multiple sclerosis	0.00016	0.00149	CbGpPWpGaD
Ticlopidine—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000157	0.00147	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR ligand binding—CCL5—multiple sclerosis	0.000157	0.00146	CbGpPWpGaD
Ticlopidine—Diarrhoea—Methotrexate—multiple sclerosis	0.000155	0.000841	CcSEcCtD
Ticlopidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	0.000152	0.00142	CbGpPWpGaD
Ticlopidine—Dizziness—Methotrexate—multiple sclerosis	0.00015	0.000813	CcSEcCtD
Ticlopidine—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000148	0.00138	CbGpPWpGaD
Ticlopidine—P2RY12—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000145	0.00135	CbGpPWpGaD
Ticlopidine—Vomiting—Methotrexate—multiple sclerosis	0.000144	0.000781	CcSEcCtD
Ticlopidine—Rash—Methotrexate—multiple sclerosis	0.000143	0.000775	CcSEcCtD
Ticlopidine—Dermatitis—Methotrexate—multiple sclerosis	0.000143	0.000774	CcSEcCtD
Ticlopidine—Headache—Methotrexate—multiple sclerosis	0.000142	0.00077	CcSEcCtD
Ticlopidine—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000142	0.00132	CbGpPWpGaD
Ticlopidine—P2RY12—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	0.000141	0.00132	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR ligand binding—CCR5—multiple sclerosis	0.000141	0.00132	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—S1PR1—multiple sclerosis	0.00014	0.00131	CbGpPWpGaD
Ticlopidine—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000139	0.0013	CbGpPWpGaD
Ticlopidine—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000139	0.0013	CbGpPWpGaD
Ticlopidine—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000137	0.00128	CbGpPWpGaD
Ticlopidine—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000137	0.00128	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—GPC5—multiple sclerosis	0.000136	0.00127	CbGpPWpGaD
Ticlopidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	0.000136	0.00127	CbGpPWpGaD
Ticlopidine—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000136	0.00127	CbGpPWpGaD
Ticlopidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	0.000135	0.00126	CbGpPWpGaD
Ticlopidine—Nausea—Methotrexate—multiple sclerosis	0.000135	0.00073	CcSEcCtD
Ticlopidine—P2RY12—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000132	0.00123	CbGpPWpGaD
Ticlopidine—CYP2B6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.00013	0.00121	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000127	0.00119	CbGpPWpGaD
Ticlopidine—CYP2E1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000127	0.00119	CbGpPWpGaD
Ticlopidine—P2RY12—Hemostasis—IL2RA—multiple sclerosis	0.000124	0.00116	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—CCL3—multiple sclerosis	0.000124	0.00116	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR downstream signaling—CCR2—multiple sclerosis	0.000124	0.00116	CbGpPWpGaD
Ticlopidine—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000121	0.00113	CbGpPWpGaD
Ticlopidine—CYP1A1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.00012	0.00112	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—PTGER4—multiple sclerosis	0.00012	0.00112	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—RGS1—multiple sclerosis	0.000119	0.00111	CbGpPWpGaD
Ticlopidine—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—multiple sclerosis	0.000116	0.00108	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—CXCR3—multiple sclerosis	0.000115	0.00108	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR downstream signaling—CNR1—multiple sclerosis	0.000114	0.00107	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—GPR65—multiple sclerosis	0.000113	0.00105	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—CCR2—multiple sclerosis	0.000112	0.00105	CbGpPWpGaD
Ticlopidine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000111	0.00104	CbGpPWpGaD
Ticlopidine—P2RY12—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	0.00011	0.00103	CbGpPWpGaD
Ticlopidine—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.00011	0.00103	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR ligand binding—POMC—multiple sclerosis	0.00011	0.00103	CbGpPWpGaD
Ticlopidine—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.00011	0.00103	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000109	0.00102	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000109	0.00102	CbGpPWpGaD
Ticlopidine—P2RY12—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	0.000108	0.00101	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR ligand binding—CCL2—multiple sclerosis	0.000108	0.00101	CbGpPWpGaD
Ticlopidine—CYP1A1—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	0.000106	0.000988	CbGpPWpGaD
Ticlopidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	0.000105	0.000985	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—CNR1—multiple sclerosis	0.000104	0.000969	CbGpPWpGaD
Ticlopidine—CYP1A1—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	0.000103	0.000966	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—CXCL13—multiple sclerosis	0.000103	0.000963	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—CCR1—multiple sclerosis	0.000103	0.000963	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000103	0.000961	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	9.96e-05	0.000931	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	9.96e-05	0.000931	CbGpPWpGaD
Ticlopidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	9.84e-05	0.00092	CbGpPWpGaD
Ticlopidine—CYP1A1—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	9.84e-05	0.00092	CbGpPWpGaD
Ticlopidine—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.8e-05	0.000917	CbGpPWpGaD
Ticlopidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	9.7e-05	0.000906	CbGpPWpGaD
Ticlopidine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	9.42e-05	0.000881	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—CXCL10—multiple sclerosis	9.33e-05	0.000873	CbGpPWpGaD
Ticlopidine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.02e-05	0.000843	CbGpPWpGaD
Ticlopidine—P2RY12—Hemostasis—ALB—multiple sclerosis	8.99e-05	0.00084	CbGpPWpGaD
Ticlopidine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.94e-05	0.000836	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	8.89e-05	0.000831	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	8.89e-05	0.000831	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR downstream signaling—CCL5—multiple sclerosis	8.85e-05	0.000827	CbGpPWpGaD
Ticlopidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	8.65e-05	0.000809	CbGpPWpGaD
Ticlopidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	8.62e-05	0.000805	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	8.11e-05	0.000758	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	8.11e-05	0.000758	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—CCL5—multiple sclerosis	8.04e-05	0.000751	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR downstream signaling—CCR5—multiple sclerosis	7.97e-05	0.000745	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR downstream signaling—IL2RA—multiple sclerosis	7.86e-05	0.000734	CbGpPWpGaD
Ticlopidine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.64e-05	0.000714	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—SRM—multiple sclerosis	7.44e-05	0.000695	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—CCL3—multiple sclerosis	7.34e-05	0.000686	CbGpPWpGaD
Ticlopidine—P2RY12—Hemostasis—IL2—multiple sclerosis	7.29e-05	0.000681	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—SRM—multiple sclerosis	7.28e-05	0.000681	CbGpPWpGaD
Ticlopidine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.27e-05	0.00068	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—CCR5—multiple sclerosis	7.24e-05	0.000677	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—IL2RA—multiple sclerosis	7.13e-05	0.000667	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—PTGER4—multiple sclerosis	7.06e-05	0.00066	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—PGR—multiple sclerosis	6.96e-05	0.00065	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	6.93e-05	0.000648	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	6.93e-05	0.000648	CbGpPWpGaD
Ticlopidine—CYP2B6—Biological oxidations—POMC—multiple sclerosis	6.89e-05	0.000644	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—SRM—multiple sclerosis	6.87e-05	0.000642	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—CXCR3—multiple sclerosis	6.82e-05	0.000638	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—CD28—multiple sclerosis	6.76e-05	0.000632	CbGpPWpGaD
Ticlopidine—CYP2E1—Biological oxidations—POMC—multiple sclerosis	6.75e-05	0.000631	CbGpPWpGaD
Ticlopidine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	6.74e-05	0.00063	CbGpPWpGaD
Ticlopidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	6.72e-05	0.000628	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—CCR2—multiple sclerosis	6.64e-05	0.00062	CbGpPWpGaD
Ticlopidine—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	6.59e-05	0.000616	CbGpPWpGaD
Ticlopidine—CYP1A1—Biological oxidations—POMC—multiple sclerosis	6.36e-05	0.000595	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—SRM—multiple sclerosis	6.3e-05	0.000589	CbGpPWpGaD
Ticlopidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	6.28e-05	0.000587	CbGpPWpGaD
Ticlopidine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	6.28e-05	0.000587	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR downstream signaling—POMC—multiple sclerosis	6.23e-05	0.000582	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—CNR1—multiple sclerosis	6.12e-05	0.000573	CbGpPWpGaD
Ticlopidine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.9e-05	0.000551	CbGpPWpGaD
Ticlopidine—CYP2C8—Biological oxidations—POMC—multiple sclerosis	5.83e-05	0.000545	CbGpPWpGaD
Ticlopidine—P2RY12—Hemostasis—TGFB1—multiple sclerosis	5.69e-05	0.000531	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—POMC—multiple sclerosis	5.66e-05	0.000529	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—SRM—multiple sclerosis	5.62e-05	0.000525	CbGpPWpGaD
Ticlopidine—P2RY12—Hemostasis—MAPK1—multiple sclerosis	5.58e-05	0.000521	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—CCL2—multiple sclerosis	5.54e-05	0.000517	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—CXCL10—multiple sclerosis	5.51e-05	0.000515	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	5.24e-05	0.00049	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	5.24e-05	0.00049	CbGpPWpGaD
Ticlopidine—CYP2C19—Biological oxidations—POMC—multiple sclerosis	5.21e-05	0.000487	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—SRM—multiple sclerosis	5.17e-05	0.000483	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—CYP24A1—multiple sclerosis	5.13e-05	0.00048	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—CYP27B1—multiple sclerosis	5.13e-05	0.00048	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—SRM—multiple sclerosis	5.12e-05	0.000479	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—TYK2—multiple sclerosis	5.03e-05	0.00047	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—CYP27B1—multiple sclerosis	4.84e-05	0.000452	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—CYP24A1—multiple sclerosis	4.84e-05	0.000452	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—CD86—multiple sclerosis	4.82e-05	0.000451	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—GPC5—multiple sclerosis	4.79e-05	0.000448	CbGpPWpGaD
Ticlopidine—CYP2D6—Biological oxidations—POMC—multiple sclerosis	4.79e-05	0.000448	CbGpPWpGaD
Ticlopidine—CYP2C9—Biological oxidations—POMC—multiple sclerosis	4.75e-05	0.000444	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—CCL5—multiple sclerosis	4.75e-05	0.000444	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.73e-05	0.000442	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—GPC5—multiple sclerosis	4.69e-05	0.000439	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR downstream signaling—IL2—multiple sclerosis	4.61e-05	0.000431	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	4.44e-05	0.000415	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	4.44e-05	0.000415	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—GPC5—multiple sclerosis	4.43e-05	0.000414	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—SPP1—multiple sclerosis	4.4e-05	0.000411	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—SRM—multiple sclerosis	4.38e-05	0.000409	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.34e-05	0.000405	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—CCR5—multiple sclerosis	4.28e-05	0.0004	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—IL2RA—multiple sclerosis	4.21e-05	0.000394	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—IL2—multiple sclerosis	4.18e-05	0.000391	CbGpPWpGaD
Ticlopidine—CYP1A2—Biological oxidations—POMC—multiple sclerosis	4.06e-05	0.000379	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—GPC5—multiple sclerosis	4.06e-05	0.000379	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—RRM1—multiple sclerosis	3.97e-05	0.000371	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	3.96e-05	0.00037	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	3.96e-05	0.00037	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—APOE—multiple sclerosis	3.89e-05	0.000364	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—RRM1—multiple sclerosis	3.89e-05	0.000364	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.87e-05	0.000362	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—RRM1—multiple sclerosis	3.67e-05	0.000343	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	3.64e-05	0.00034	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	3.64e-05	0.00034	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—GPC5—multiple sclerosis	3.62e-05	0.000339	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	3.61e-05	0.000337	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	3.61e-05	0.000337	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.53e-05	0.00033	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—CD80—multiple sclerosis	3.52e-05	0.000329	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—SRM—multiple sclerosis	3.38e-05	0.000316	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—RRM1—multiple sclerosis	3.36e-05	0.000314	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—POMC—multiple sclerosis	3.34e-05	0.000312	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—GPC5—multiple sclerosis	3.33e-05	0.000311	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—GPC5—multiple sclerosis	3.3e-05	0.000309	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—CCL2—multiple sclerosis	3.27e-05	0.000306	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—MAPK1—multiple sclerosis	3.2e-05	0.000299	CbGpPWpGaD
Ticlopidine—CYP3A4—Biological oxidations—POMC—multiple sclerosis	3.13e-05	0.000293	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	3.09e-05	0.000288	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	3.09e-05	0.000288	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.02e-05	0.000282	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—RRM1—multiple sclerosis	3e-05	0.00028	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—TYK2—multiple sclerosis	2.97e-05	0.000278	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.84e-05	0.000266	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—GPC5—multiple sclerosis	2.82e-05	0.000264	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—RRM1—multiple sclerosis	2.76e-05	0.000258	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—RRM1—multiple sclerosis	2.74e-05	0.000256	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.61e-05	0.000244	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—IL2—multiple sclerosis	2.47e-05	0.000231	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—IL6—multiple sclerosis	2.46e-05	0.00023	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.44e-05	0.000228	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.38e-05	0.000223	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.38e-05	0.000223	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—MMP9—multiple sclerosis	2.34e-05	0.000219	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—RRM1—multiple sclerosis	2.34e-05	0.000219	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.33e-05	0.000218	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—BCHE—multiple sclerosis	2.28e-05	0.000213	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.24e-05	0.000209	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—BCHE—multiple sclerosis	2.23e-05	0.000209	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.23e-05	0.000208	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.18e-05	0.000204	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.12e-05	0.000198	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—BCHE—multiple sclerosis	2.11e-05	0.000197	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—STAT3—multiple sclerosis	2.08e-05	0.000194	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.04e-05	0.000191	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2e-05	0.000187	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—MYC—multiple sclerosis	1.93e-05	0.000181	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—BCHE—multiple sclerosis	1.93e-05	0.00018	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—TGFB1—multiple sclerosis	1.93e-05	0.00018	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—MAPK1—multiple sclerosis	1.89e-05	0.000177	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.82e-05	0.00017	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.82e-05	0.00017	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.81e-05	0.00017	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.8e-05	0.000169	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.72e-05	0.000161	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.66e-05	0.000155	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.59e-05	0.000148	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.57e-05	0.000147	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.56e-05	0.000146	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—IL6—multiple sclerosis	1.45e-05	0.000136	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.42e-05	0.000133	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—APOE—multiple sclerosis	1.37e-05	0.000128	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—APOE—multiple sclerosis	1.34e-05	0.000126	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.34e-05	0.000126	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—APOE—multiple sclerosis	1.27e-05	0.000118	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—POMC—multiple sclerosis	1.18e-05	0.00011	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—APOE—multiple sclerosis	1.16e-05	0.000109	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—POMC—multiple sclerosis	1.15e-05	0.000108	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—POMC—multiple sclerosis	1.09e-05	0.000102	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—ALB—multiple sclerosis	1.07e-05	0.0001	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—ALB—multiple sclerosis	1.05e-05	9.84e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—APOE—multiple sclerosis	1.04e-05	9.69e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.04e-05	9.69e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—POMC—multiple sclerosis	9.98e-06	9.33e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—ALB—multiple sclerosis	9.92e-06	9.28e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—APOE—multiple sclerosis	9.54e-06	8.91e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—APOE—multiple sclerosis	9.45e-06	8.84e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—ALB—multiple sclerosis	9.1e-06	8.5e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—POMC—multiple sclerosis	8.91e-06	8.33e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—POMC—multiple sclerosis	8.19e-06	7.66e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—POMC—multiple sclerosis	8.12e-06	7.59e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—ALB—multiple sclerosis	8.12e-06	7.59e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—APOE—multiple sclerosis	8.08e-06	7.55e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—ALB—multiple sclerosis	7.47e-06	6.98e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—ALB—multiple sclerosis	7.4e-06	6.92e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—POMC—multiple sclerosis	6.94e-06	6.49e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—ALB—multiple sclerosis	6.33e-06	5.91e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—APOE—multiple sclerosis	6.23e-06	5.83e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—POMC—multiple sclerosis	5.36e-06	5.01e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—ALB—multiple sclerosis	4.88e-06	4.56e-05	CbGpPWpGaD
